Lourd Capital’s Thermo Fisher Scientific TMO Stock Holding History

Lourd Capital’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$447K	Buy	1,521 +618	+68%	+$170K	0.04%	68
2019 Q1	$247K	Sell	903 -1,204	-57%	-$300K	0.02%	106
2018 Q4	$472K	Buy	2,107 +120	+6%	+$28.2K	0.04%	125
2018 Q3	$485K	Buy	+1,987	New	+$457K	0.03%	134
2018 Q1	–	Sell	-1,993	Closed	-$378K	–	311
2017 Q4	$378K	Buy	1,993 +427	+27%	+$81.8K	0.02%	197
2017 Q3	$296K	Buy	1,566 +3	+0.2%	+$543	0.03%	93
2017 Q2	$273K	Buy	+1,563	New	+$263K	0.03%	97

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Lourd Capital's TMO Position: Q2 2019 in Review

Lourd Capital increased its Thermo Fisher Scientific (TMO) stake by 68% in Q2 2019, buying an estimated $170K and bringing the position to 1,521 shares worth $447K. The position accounts for 0.04% of the portfolio, ranked #68.

Lourd Capital first reported a position in TMO in Q2 2017 and has held it in 7 quarters since. The position peaked at $485K in Q3 2018. 1,559 funds tracked by Wall St. Rank hold TMO as of Q2 2019.

Lourd Capital held 1,521 shares of Thermo Fisher Scientific worth $447K as of Q2 2019.
Lourd Capital bought 618 Thermo Fisher Scientific shares in Q2 2019, an estimated $170K.
Thermo Fisher Scientific made up 0.04% of Lourd Capital's portfolio in Q2 2019, its #68 holding.
Lourd Capital first reported a position in Thermo Fisher Scientific in Q2 2017 and has held it in 7 quarters since.
Lourd Capital's Thermo Fisher Scientific position peaked at $485K in Q3 2018.
1,559 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2019.

Based on Lourd Capital's 13F filing for Q2 2019, filed 11 Jul 2019.